Skip to main content
OpenTrials

Clinical trial condition

Sintilimab

Explore clinical trials studying Sintilimab. Study availability and eligibility vary by location and protocol.

14 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Sintilimab trial results

Recruiting

The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients

NCT07138755

Conditions
Adaptive Radiotherapy, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Xiangya 3rd Hospital, Central South University Changsha, Hunan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • The First Affiliated Hospital of Nanhua University Hengyang, Hunan, China
  • Xiangxi Tujia and Miao Autonomous Prefecture People's Hospital Jishou, Hunan, China
View Trial Details
Recruiting

A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer

NCT07506109

Conditions
BRAF V600E, Brain Diseases, Central Nervous System Diseases, +25 more
Locations
  • Peking union medical college hospital Beijing, Beijing Municipality, China
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • West China Hospital Sichuan University Chengdu, Sichuan, China
  • Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions